The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Moreover authentication and authorization for users is implemented. The web-application is also secured against SQL Injection and Cross-Site Scripting attacks.

South Carolina's execution chamber. (Provided/SC Department of Corrections) COLUMBIA — The state’s law keeping information about lethal injection drugs secret violates constitutional rights to free ...

The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the trial.

Varner was only able to stay on the medication using Social Security disability support. She said if she didn’t have insurance, a month’s worth of injections would cost her nearly $60,000— more than ...

Side effects of biologic drugs may include: respiratory infections headaches flu-like symptoms swelling, itching, or a rash at the injection site urinary tract infection Two types of biologic ...

Follow all your provider’s instructions about medicines and follow-up care. Make sure to keep all your future appointments. The procedure may not work well if you don't get the full series of ...

Omalizumab is generally well tolerated in adults and children with allergic asthma. Adverse events most commonly observed are injection-site reaction, viral infection, upper-respiratory-tract ...

Instead, he listed them on iPads handed to patients after they arrived, and instructed his employees never to take pictures of him performing injections, prosecutors said. When clients complained ...

they are likely to miss some of the important instructions to be announced in the examination rooms/ halls. The NTA will not be responsible for any delay of the candidate to reach the examination ...